European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

144 citing papers in PubMed, 4 syntheses or guidelines pooled it.

1. Inequities in glaucoma research: an analysis of Cochrane systematic reviews and randomized trials.Journal of clinical epidemiology · 2025
   Pooled it
2. Eliciting preferences in glaucoma management-a systematic review of stated-preference studies.Eye (London, England) · 2023
   Pooled it
3. Comparison of Netarsudil/Latanoprost Therapy with Latanoprost Monotherapy for Lowering Intraocular Pressure: A Systematic Review and Meta-analysis.Korean journal of ophthalmology : KJO · 2022
   Pooled it
4. Cyclodestructive procedures for non-refractory glaucoma.The Cochrane database of systematic reviews · 2018
   Pooled it
5. Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial.Clinical ophthalmology (Auckland, N.Z.) · 2024
   Trial
6. Sutureless versus conventional deep sclerectomy for management of open angle glaucoma.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
   Trial
7. Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2022
   Trial
8. Subtenon triamcinolone as an adjuvant in mitomycin-C-enhanced trabeculectomy in non-inflammatory glaucomas: A randomized clinical trial.PloS one · 2022
   Trial
9. Twelve-month efficacy and safety of omidenepag isopropyl, a selective EP2 agonist, in open-angle glaucoma and ocular hypertension: the RENGE study.Japanese journal of ophthalmology · 2021
   Trial
10. Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study.Japanese journal of ophthalmology · 2020
    Trial
11. A Comparative Analysis of Intraocular Pressure Measurement across Different Tonometry Methods and Experience Levels.Korean journal of ophthalmology : KJO · 2026
    Observational
12. Management and outcomes of primary open-angle glaucoma.Journal of family medicine and primary care · 2026
    Review
13. Visual field progression in varying severities of treated patients with primary angle closure glaucoma.Scientific reports · 2026
    Article
14. Knowledge, attitude and practice towards glaucoma among ophthalmic inpatients: a cross-sectional study in Hunan, China.BMJ open · 2026
    Article
15. Phacoemulsification with IOL implantation combined with goniosynechialysis and goniotomy in primary angle-closure glaucoma following failed trabeculectomy: short-term effectiveness and safety outcomes.Frontiers in medicine · 2026
    Article
16. Structure-Function Relationship in Patients with Glaucoma Suspect: Diagnostic Value and Changes During Follow-up.Beyoglu eye journal · 2026
    Article
17. Hypotension and antiphlogistic potential of empagliflozin ocular film: swelling and release kinetics.ADMET & DMPK · 2026
    Article
18. Comparison of Circadian Efficacy of Tafluprost Eye Drops (Taflotan SineJournal of clinical medicine · 2025
    Article
19. Outcomes of intraluminal ripcord removal from Paul glaucoma implants.The British journal of ophthalmology · 2025
    Article
20. Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies.Advances in therapy · 2025
    Article

84 more citing papers are in PubMed but not listed here.

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as